ALK Positive (@ALKPositiveinc) header
ALK Positive (@ALKPositiveinc) profile picture

ALK Positive

@ALKPositiveinc

We are a patient-driven organization, dedicated to improving the life expectancy & quality of life for ALK-positive cancer patients worldwide. #StrongerTogether

 United States
alkpositive.org
Joined May 2018
  • Tweets3.8K
  • Following911
  • Followers2.9K
1.1KMedia
Photo by ALK Positive (@ALKPositiveinc)Photo by ALK Positive (@ALKPositiveinc)Photo by ALK Positive (@ALKPositiveinc)Photo by ALK Positive (@ALKPositiveinc)Photo by ALK Positive (@ALKPositiveinc)Photo by ALK Positive (@ALKPositiveinc)Photo by ALK Positive (@ALKPositiveinc)Photo by ALK Positive (@ALKPositiveinc)Photo by ALK Positive (@ALKPositiveinc)Photo by ALK Positive (@ALKPositiveinc)
Navigating the practical and financial challenges after an ALK-positive diagnosis can feel overwhelming. Our partner, Triage Health, is hosting a FREE virtual conference for patients, care partners, & healthcare professionals. Nov 6 & 7 TriageHealth.org/Conferences #TriageTalks
Image from ALK Positive (@ALKPositiveinc)
118
📣 #ESMO26 | HER-LUNG UK Proud to present our research on the experiences and unmet needs of younger women with lung cancer in 🇬🇧 Building on these findings, HER-ALERT aims to improve earlier recognition of lung cancer in younger women who have never smoked. Grateful to the @Roy_Castle_Lung for funding HER-LUNG UK and supporting this important research. Thanks to co-investigators @Yvonne_Diaz_ @NarjustFlorezMD Dr Florien Boele and @KathrynBanfill Dr Gordon and all the patients and caregivers who partecipated #ESMO26 #HERLUNG #HERALERT #LungCancer #HYMS @HullYorkMed @myESMO
Image from Cecilia Pompili MD PhD FACS (@pompili_cecilia)
Image from Cecilia Pompili MD PhD FACS (@pompili_cecilia)
1
8
14
687
One dinner out can make a difference! 💚 Kelly and Larry bring their community together through an annual @RedRobin fundraiser supporting ALK+ cancer research. Have an idea of your own? Turn it into impact! Start fundraising today: alkpositive.org/fundraise-wi…
1
162
We’re proud to partner with Triage Cancer for the Triage Health Conference. This FREE virtual event covers health insurance options, advocacy, managing finances, and more. Health care professionals can earn free CE. Nov 6 & 7 TriageCancer.org/Conferences #TriageTalks #HealthCareRights
Image from ALK Positive (@ALKPositiveinc)
3
179
ALK Positive is honored to contribute $50,000 to the Ross Camidge, MD, PhD, Thoracic Oncology Endowed Program Support Fund. With deep gratitude for Dr. Camidge’s lasting impact, we’re proud to support the future of thoracic oncology. buff.ly/xupfzXJ
Image from ALK Positive (@ALKPositiveinc)
3
9
395
🌍 ALK Positive is headed to #ESMO2026! Dr. Ken Culver and Yvonne Diaz will be connecting with physicians, researchers, and global partners to advance ALK-positive cancer research and amplify patient voices worldwide.
Image from ALK Positive (@ALKPositiveinc)
3
12
510
ALK Positive retweeted
Yvonne Diaz (@Yvonne_Diaz_) profile picture
Yvonne Diaz@Yvonne_Diaz_Oct 18
Don’t miss this joint ALKtALK from @ALKPositiveinc and @EGFRResisters with Dr @kyleconcannonMD (aka @Cracking_Cancer). Today, Sunday 18 Oct at 7pm ET. 🔗 alkpositive.org/living-with-…
ALKtALK by ALK Positive

ALKtALK by ALK Positive

Our ALKtALKs feature ALK experts, research teams, leading thoracic and palliative care physicians, and mental health professionals.

alkpositive.org
ALK Positive (@ALKPositiveinc) profile pictureALK Positive@ALKPositiveincOct 17
🧬 Could CAR T-cell therapy offer a new way to treat lung cancer? Join ALK Positive & EGFR Resisters tomorrow, Oct. 18, at 7 PM ET for a special ALKtALK with Dr. Kyle Concannon exploring ACES CAR T-cell research and its potential for ALK, EGFR & other lung cancers.
Image from ALK Positive (@ALKPositiveinc)
5
1
11
466
🧬 Could CAR T-cell therapy offer a new way to treat lung cancer? Join ALK Positive & EGFR Resisters tomorrow, Oct. 18, at 7 PM ET for a special ALKtALK with Dr. Kyle Concannon exploring ACES CAR T-cell research and its potential for ALK, EGFR & other lung cancers.
Image from ALK Positive (@ALKPositiveinc)
1
5
1
11
668
ALKtALK replay is now available! What’s new in ALK-positive cancer research, and what could it mean for you? Dr. Ken Culver shares clinical trial updates, emerging research, and a preview of our November Lung Cancer Awareness Month campaign! ▶️ Watch: youtu.be/r3ocrSEb-jc
Image from ALK Positive (@ALKPositiveinc)
9
385
What does survivorship mean when living with ALK-positive cancer? In this ALKtALK clip, @lungoncdoc shares why survivorship goes beyond treatment to include quality of life, adapting, and living well. 🎥 Watch the full replay: youtu.be/aIVlb1OiWxU #ALKPositive #ALKtALK
1
3
7
429
How could we find new cancer treatments faster? ALK Positive helped fund researchers at @BIDMChealth @DanaFarber & more to help immune cells attack cancer. Early results are in lymphoma; the approach is now being explored in #lungcancer. 🔗bidmc.org/news-stories/all-n… #LCSM
Image from ALK Positive (@ALKPositiveinc)
1
176
What does progress in #lungcancer mean for everyday life? Why do patient voices matter in research? Our Chair & @ALKPositiveinc BoD @Yvonne_Diaz_ & @DrYolaOLO discuss this & more from #WCLC26 in a takeover of @IASLC’s Lung Cancer Considered podcast. 🎧 bit.ly/3TA4gv3
Image from Oncogene Cancer Research (@OncogeneCancer)
3
4
239
🔬 What’s next in ALK-positive cancer research? Join us Sunday, Oct. 4 at 7 PM ET for ALKtALK with Dr. Ken Culver, featuring updates on emerging research, clinical trials, the Global ALK Alliance + an early preview of Lung Cancer Awareness Month. 🔗 alkpositive.org/event/alktal…
Image from ALK Positive (@ALKPositiveinc)
1
3
11
352
Proud of Dr. Ido Haimi presenting our work at @AATSHQ #ITSOS2026! Beyond local control, lung resection informed changes in care for nearly 1 in 4 patients with metastatic NSCLC in our cohort. Surgery provides tissue that can guide what comes next.
Image from Mara Antonoff, MD, FACS (@maraantonoff)
Image from Mara Antonoff, MD, FACS (@maraantonoff)
Image from Mara Antonoff, MD, FACS (@maraantonoff)
Image from Mara Antonoff, MD, FACS (@maraantonoff)
9
25
1,656
ALKtALK Season 7 premieres Sunday, Sept. 27 at 7 p.m. ET with Dr. Eric Singhi @lungoncdoc of MD Anderson. Join us on Zoom for WCLC updates, practical information for life with ALK-positive cancer, and live Q&A. alkpositive.org/event/alktal… #ALKtALK #ALKPositive
Image from ALK Positive (@ALKPositiveinc)
1
3
7
355
8yr ADAURA update 🔥 informs cure vs delay-relapse debate 👉 77% pts surv data Overall: 8yr OS 79 v 64% HR 0.52 II-IIIA: 8yr OS 74 v 58% HR 0.53 🤔 Durable OS benefit ➡️ cure for some, albeit not for all ❓optimal Osi duration ❓risk stratification w MRD ❓sequencing #WCLC26
Image from Tom Newsom-Davis (@tnewsomdavis)
Image from Tom Newsom-Davis (@tnewsomdavis)
Image from Tom Newsom-Davis (@tnewsomdavis)
5
7
506
ALK Positive retweeted
OncLive.com (@OncLive) profile picture
OncLive.com
@OncLiveSep 12
What IS the optimal treatment for a patient with locally advanced stage IIIA NSCLC with an ALK fusion? @StephenVLiu weighs in following a thoughtful discussion at the #BTGLung2026 meeting #lcsm @Georgetown @MedStarGUH @LombardiCancer
6
44
2,488
ALK Positive retweeted
Yvonne Diaz (@Yvonne_Diaz_) profile picture
Yvonne Diaz@Yvonne_Diaz_Sep 14
Dr @mal_itchins highlights 19 yrs of progress in ROS1 w latest data on zidesamtinib at #WCLC26. Congratulates work by @RO1ders @jfreemandaily Lilian Leigh @ProjectBreath. “12 yrs ago we didn’t test for ROS1 in Australia but thanks to a #clinicaltrial Lillian is still here today.” – at Gangnam-gu, Republic of Korea
Image from Yvonne Diaz (@Yvonne_Diaz_)
Image from Yvonne Diaz (@Yvonne_Diaz_)
Image from Yvonne Diaz (@Yvonne_Diaz_)
Image from Yvonne Diaz (@Yvonne_Diaz_)
1
8
21
699
ALK Positive retweeted
Yvonne Diaz (@Yvonne_Diaz_) profile picture
Yvonne Diaz@Yvonne_Diaz_Sep 14
Great to see more studies & focus on our EGFR exon 20 lung cancer population w presentations by @chulkimMD @danieltanmd and Dr Lyudmila Bazhenov at #WCLC26 @JillFeldman4 challenges on why data on reduced doses is not presented. Staying on treatment is key. Panel agrees – at Gangnam-gu, Republic of Korea
Image from Yvonne Diaz (@Yvonne_Diaz_)
Image from Yvonne Diaz (@Yvonne_Diaz_)
Image from Yvonne Diaz (@Yvonne_Diaz_)
1
10
15
848
🆙 #WCLC26 #LCSM Mini Oral Session 🔥 A Pivotal Phase II Study of Ficonalkib, a 3rd-Generation ALK-TKI, in Advanced ALK-Positive NSCLC After 2nd-Generation ALK-TKI Failure 🎯ORR 43.1%, median PFS 9.7 mo, median DoR 15.2 mo 🎯Intracranial ORR 65.0% 🎯Most common TRAE diarrhea (71.9%); no neurologic toxicities 🎙️ Dr. Yuankai Shi 🔢 MO12.08 ☑️ NCT05869162 🔗 cattendee.abstractsonline.co… @OncoAlert @Larvol @IASLC @ALKPositiveinc
Image from Hidehito HORINOUCHI (@HHorinouchi)
1
4
1
11
2,210
Load more